Registered entities
VAXART, INC.
Reg. No. 59-1212264United States
AVIRAGEN THERAPEUTICS, INC.
Reg. No. 72444United States
Innovation
16 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 712 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 10.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Quantum Technology Partners, Life Science Angels, Care Capital, Care Capital Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Angel & family office | 1 | 10% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 2 | 20% |
Recent activity
25 Jun 2026
Event
2026 Biotechnology Innovation Organization International Convention
15 Jun 2026
Event
2026 Biotechnology Innovation Organization's International Convention